Relestat
Relestat is a medicine authorised by Swissmedic under authorisation number 56310. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 December 2004 and the authorisation is valid without a time limit. ATC code S01GX places the medicine in the group Ophthalmologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Relestat, Augentropfen | B | 07 December 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | ml | S01GX | 11.06.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Relestat authorised in Switzerland?
Yes. Relestat is authorised by Swissmedic under authorisation number 56310, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Relestat have?
Relestat is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Relestat?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.